TENX Stock Analysis: Buy, Sell, or Hold?
TENX - Tenax Therapeutics, Inc.
$13.64
1.39 (11.35%)
▲
5d:
+18.1%
30d:
+10.36%
90d:
-4.41%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When TENX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TENX is 12.8% above its trading range ($12.09). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TENX is 12.8% above its trading range ($12.09). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TENX is currently trading at $13.64, which is considered slightly high relative to its 30-day fair value range of $11.00 to $12.09.
Technical Outlook: Technically, TENX is in a downtrend. The price is approaching resistance at $12.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.3% recently.
Market Sentiment: TENX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.88 (+148.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TENX is in a downtrend. The price is approaching resistance at $12.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.3% recently.
Market Sentiment: TENX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.88 (+148.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$11.00 -
$12.09
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.3%)
- BULLISH: Trading 148.4% below Wall St target ($33.88)
- WARNING: Recommendation downgraded due to 12.8% overvaluation
Trading Range Analysis
30-Day Trading Range
$11.00 -
$12.09
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$10.25
Resistance Level
$12.44
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.80
Wall Street Target
$33.88
(+148.4%)
Share & Embed Analysis
Last updated: June 23, 2026 10:30 PM ET
Data refreshes hourly during market hours. Next update: 11:30 PM
Data refreshes hourly during market hours. Next update: 11:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TENX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 60 BUY |
